USPTO serial 88677074
SMARTDOSE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SIMCOX, KYLE DUNCAN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SMARTDOSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rex A. Donnelly
Rex A. Donnelly RATNERPRESTIA2200 RENAISSANCE BLVD, SUITE 350KING OF PRUSSIA, PA 19406United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Infusion pumps, sold pre-filled, for facilitating subcutaneous delivery of a wide range of liquid pharmaceutical preparations to patients; infusion pumps sold pre-filled with fluids used for the subcutaneous delivery of pharmaceutical preparations to patients; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with insulin | ACTIVE | — |
| 009 | downloadable computer application software for mobile phones and handheld computers, namely, interactive patient engagement and medication adherence software for users of wearable injector drug delivery systems; downloadable computer software for facilitating communication between a computer or handheld device connected to the internet and an wearable injector drug delivery system; downloadable mobile applications for communicating with an wearable injector drug delivery system and for displaying health related information | ACTIVE | — |
| 035 | arranging and conducting incentive reward programs for promoting consumer compliance with prescriptions for medications delivered by wearable injector drug delivery systems; promoting data collection used in improving healthcare administration and cost management in connection with wearable injector drug delivery systems by providing an interactive web site where users can provide information about health and fitness in the nature of their health programs, personal health data and prescription and health conditions, in exchange for promotional rewards consisting of discounts and special offerings on goods and/or services provided by website sponsors | ACTIVE | — |
| 038 | telecommunications services, namely, providing e-mail and text messages notification via the internet, featuring alerts, reminders and information related to compliance with health programs relating to wearable injector drug delivery systems | ACTIVE | — |
| 042 | Computer services, namely, providing an interactive web site featuring technology that allows users to communicate information from wearable injector drug delivery systems; Providing temporary use of non-downloadable computer software for communicating with wearable injector drug delivery systems and for displaying health related information; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to wearable injector drug delivery systems; Providing on-line non-downloadable software for authenticating and rewarding compliance with health programs, namely, prescriptions for medications and medical treatment regimens related to wearable injector drug delivery systems; Providing on-line non-downloadable software for users to receive notifications via e-mail, instant message, short message service (SMS), multimedia message service (MMS) or text messages relating to wearable injector drug delivery systems; Research and development and consultation related thereto in the field of wearable injector drug delivery systems | ACTIVE | — |
| 044 | Providing health care information relating to wearable injector drug delivery systems by global computer networks and electronic means | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by West Pharma. Services IL, Ltd.
- Other trademarks owned by West Pharma. Services IL, Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SMARTDOSE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 4, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 4, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 29, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 27, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 27, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 27, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 6, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 4, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 4, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 4, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 29, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 27, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 27, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 27, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 28, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 26, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 26, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 26, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 27, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 1, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 1, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 12, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 21, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 8, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 8, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 14, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 14, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 14, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 5, 2019 | NWAP | NEW APPLICATION ENTERED | — |